Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) EPS (Weighted Average and Diluted) (2019 - 2025)

TELA Bio (TELA) has 7 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.19 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 54.76% year-over-year to -$0.19; the TTM value through Sep 2025 reached -$0.83, up 50.89%, while the annual FY2024 figure was -$1.33, 34.8% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.19 in Q3 2025 per TELA's latest filing, up from -$0.22 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.17 in Q4 2024 and bottomed at -$0.87 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.48, with a median of -$0.51 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 52.63% in 2022, then skyrocketed 67.92% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.59 in 2021, then increased by 18.64% to -$0.48 in 2022, then decreased by 10.42% to -$0.53 in 2023, then surged by 67.92% to -$0.17 in 2024, then dropped by 11.76% to -$0.19 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.19 in Q3 2025, -$0.22 in Q2 2025, and -$0.25 in Q1 2025.